0001144204-16-078901.txt : 20160204
0001144204-16-078901.hdr.sgml : 20160204
20160204061237
ACCESSION NUMBER: 0001144204-16-078901
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160204
DATE AS OF CHANGE: 20160204
EFFECTIVENESS DATE: 20160204
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kitov Pharmaceuticals Holdings Ltd.
CENTRAL INDEX KEY: 0001614744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-256678
FILM NUMBER: 161386741
BUSINESS ADDRESS:
STREET 1: LEV HAGIVA, 11 BET HADFUS ST.,
CITY: JERUSALEM
STATE: L3
ZIP: 95483
BUSINESS PHONE: 011972525328200
MAIL ADDRESS:
STREET 1: LEV HAGIVA, 11 BET HADFUS ST.,
CITY: JERUSALEM
STATE: L3
ZIP: 95483
D
1
primary_doc.xml
X0707
D
LIVE
0001614744
Kitov Pharmaceuticals Holdings Ltd.
ONE AZRIELI CENTER,
ROUND BUILDING, 23RD FLOOR
TEL AVIV
L3
ISRAEL
6701101
011972525328200
ISRAEL
Mainrom Line Logistics Ltd.
None
Other
Limited company
true
Isaac
Israel
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Director
Simcha
Rock
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Director
John Paul
Waymack
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Director
Philip
Serlin
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Director
Moran
Sherf-Blau
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Director
Alain
Zeitoun
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Director
Gil
Ben-Menachem
One Azrieli Center,
Round Building, 23rd Floor
Tel Aviv
L3
ISRAEL
6701101
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-01-20
false
true
false
0
Indefinite
0
Indefinite
A private placement to a vendor of the Filer of up to 24,000 of the Filer's ADSs (8,000 having been issued) which are being offered in consideration for services provided to the Filer.
false
1
0
0
0
See clarification to item 13 above.
false
Kitov Pharmaceuticals Holdings Ltd.
/s/ Simcha Rock
Simcha Rock
Chief Financial Officer and Director
2016-02-04